Last edition
News about "Amgen BioPharma "
Amgen Acquires UK- based Dark Blue Therapeutics in 840M USD Deal
Amgen’s acquisition of Dark Blue Therapeutics, adds a first-in-class protein degrader programme targeting MLLT1/3-driven acute myeloid leukemia to strengthen its early-stage oncology pipeline.<br />
Amgen BioPharma | 07/01/2026 | By News Bureau | 123
PBS Biotech Appoints Martin Simonetti as CEO
Simonetti is a veteran biotech executive who brings more than 40 years' industry expertise and leadership to PBS Biotech, including C-suite leadership, public and private financing and executing large-scale pharmaceutical collaborations.
Amgen BioPharma | 04/11/2025 | By Dineshwori | 282
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy